Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-07-17 00:00:00 ET · period of report 2024-07-15 · accession 0000874015-24-000181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-17 | 2024-07-15 | IONS | LOSCALZO JOSEPH | Dir | M - OptEx | $0.00 | +4,677 | 45.8K | +11% | $0 |
| D | 2024-07-17 | 2024-07-15 | IONS | LOSCALZO JOSEPH | Dir | M - OptEx | $0.00 | -4,677 | 4,079 | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-15 | M | A | 4,677 | $0.00 | 45,759 | D | — | — | (F1) Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. |
| 2 | Derivative | Restricted Stock Unit | 2024-07-15 | M | D | 4,677 | $0.00 | 4,079 | D | $0.00 · — to — | 4,677 Common Stock | (F2) Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. (F3) Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. |